Ho Young Lim
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 9
- Colorectal Cancer Treatments and Studies 5
-
- Gastric Cancer Management and Outcomes 5
- Pleural and Pulmonary Diseases 2
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Ann‐Lii Cheng (1 shared paper)Samuel E. DePrimo (1 shared paper)Ana Ruiz-Garcı́a (1 shared paper)Sandrine Faivre (1 shared paper)Jean-Yves Douillard (1 shared paper)Éveline Boucher (1 shared paper)Éric Raymond (1 shared paper)Silvana Lanzalone (1 shared paper)
- Journals
- Investigational New Drugs (2 papers)Targeted Oncology (1 paper)Japanese Journal of Clinical Oncology (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)The Oncologist (1 paper)
- Partner nations
- South KoreaItalyUnited States
In The Last Decade
Ho Young Lim
17 papers receiving 468 citations
Peers
Comparison fields: 5 of 64
- Hepatology 178
- Gastroenterology 44
- Pathology and Forensic Medicine 122
- Oncology 175
- Pulmonary and Respiratory Medicine 163
Countries citing papers authored by Ho Young Lim
This map shows the geographic impact of Ho Young Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Young Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Young Lim more than expected).
Fields of papers citing papers by Ho Young Lim
This network shows the impact of papers produced by Ho Young Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Young Lim. The network helps show where Ho Young Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Ho Young Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 219 | |
| 2 | 2009 | 68 | |
| 3 | 2011 | 52 | |
| 4 | 2011 | 41 | |
| 5 | 2007 | 30 | |
| 6 | 1992 | 23 | |
| 7 | 2011 | 14 | |
| 8 | 2006 | 12 | |
| 9 | 1991 | 6 | |
| 10 | 2010 | 4 | |
| 11 | Two Cases with Squamous Cell Carcinoma of the Thyroid Gland | 2001 | 3 |
| 12 | 2022 | 2 | |
| 13 | Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision? | 2002 | 2 |
| 14 | 2019 | 2 | |
| 15 | 2019 | 1 | |
| 16 | 2001 | 1 | |
| 17 | 2006 | 1 | |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 |
About Ho Young Lim
Ho Young Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Pathology and Forensic Medicine, having authored 19 papers that have together received 481 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Gastric Cancer Management and Outcomes (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Pleural and Pulmonary Diseases (2 papers), Security and Verification in Computing (2 papers), Advanced Malware Detection Techniques (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Hepatology (178 citations), Gastroenterology (44 citations), Pathology and Forensic Medicine (122 citations), Oncology (175 citations) and Pulmonary and Respiratory Medicine (163 citations). Ho Young Lim has collaborated with scholars based in South Korea, Italy and United States. Frequent co-authors include Ann‐Lii Cheng, Samuel E. DePrimo, Ana Ruiz-Garcı́a, Sandrine Faivre, Jean-Yves Douillard, Éveline Boucher, Éric Raymond, Silvana Lanzalone, María José Lechuga and Charles S. Harmon. Their work appears in journals such as Investigational New Drugs, Targeted Oncology, Japanese Journal of Clinical Oncology, Bioorganic & Medicinal Chemistry Letters and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.